Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Amid the torrent of products announced earlier in January at the Consumer Electronics Show, like giant televisions and absurdly expensive GPUs, it's easy to miss less fun but potentially life-changing ...

Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration affects 7–8% of the population, and its incidence increases with age.

XT-150 is under development for the treatment of peripheral neuropathic pain-lumbar radiculopathy, central neuropathic pain, multiple sclerosis, facet syndrome, osteoarthritis, osteoarthritis pain, ...

Purpose: This study aims to investigate microvascular changes in the macular and peripheral regions, as well as alterations in the foveal avascular zone (FAZ) of the ipsilateral eye using widefield ...

A clever new set of glasses may offer new hope to people with macular degeneration ... facing camera's picture onto the still-healthy peripheral area of the retina, from a subtly different ...

Age-related macular degeneration (AMD) is the leading cause of vision loss for people over 65. We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any ...

Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries. Nature Genetics , 2024; 56 (12): 2659 DOI: 10.1038/s41588-024-01764 ...

“One of the most important known PCDs is retinitis pigmentosa (RP), which is a blinding disease associated with mutations in the rod opsin (RHO) gene among other retina-specific genes.

A new study from Karolinska Institutet and Mayo Clinic has revealed important insights into brain degeneration in dementia with Lewy bodies (DLB). This research, published in JAMA Neurology ...